HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
NBI-56418
Description
NBI-56418 is a proprietary, orally active small molecule Gonadotropin-Releasing Hormone (GnRH) receptor antagonist that could diminish bone demineralisation. It is being developed by Neurocrine Biosciences.
No brand information found.
